(Q46109640)

19 December 2017

title

Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem (English)

1 reference

19 December 2017

1 reference

3

J S Harmatz

1 reference

19 December 2017

David J. Greenblatt

6

object named as

D J Greenblatt

1 reference

19 December 2017

Lisa L. von Moltke

4

object named as

L L von Moltke

1 reference

19 December 2017

Michael H Court

5

object named as

M H Court

1 reference

19 December 2017

author name string

D Farkas

1

1 reference

19 December 2017

L P Volak

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

25 February 2009

1 reference

19 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

19 December 2017

volume

85

1 reference

19 December 2017

page(s)

644-650

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

Macrolides and ketolides: azithromycin, clarithromycin, telithromycin

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Pharmacokinetic drug interactions of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Macrolide antibacterials. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Pharmacokinetic drug interactions with antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Clinical pharmacokinetics of clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Rapidly distinguishing reversible and irreversible CYP450 inhibitors by using fluorometric kinetic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Behavioral pharmacology of zolpidem relative to benzodiazepines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Zolpidem: a review of its use in the management of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

GABA(A) receptor diversity and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Interactions of trazodone with serotonin neurons and receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Trazodone hydrochloride: a wide spectrum antidepressant with a unique pharmacological profile. A review of its neurochemical effects, pharmacology, clinical efficacy, and toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Effect of the treatment period with erythromycin on cytochrome P450 3A activity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Interaction between midazolam and clarithromycin in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

A potentially hazardous interaction between erythromycin and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Absorption rate, blood concentrations, and early response to oral chlordiazepoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Sedative effects and impaired learning and recall after single oral doses of lorazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

7 January 2021

Structure, pharmacology, and function of GABAA receptor subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

7 January 2021

Alprazolam-ritonavir interaction: implications for product labeling

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

7 January 2021

Sensitivity to triazolam in the elderly.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

7 January 2021

Analysis of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection: application to single-dose pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.293

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.293

1 reference

19 December 2017

PubMed ID

19242403

1 reference

19 December 2017